
NeoGenomics (NEO) Earnings Dates & Reports
NeoGenomics (NEO) Most Recent Earnings
Report DateFeb 18, 2025
Period EndingQ4 2024
Est. EPS$0.03
Actual EPS$0.04
EarningsBeat
NeoGenomics (NEO) Earnings
View the latest NeoGenomics (NEO) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in NeoGenomics (NEO)
Order type
Buy in
Order amount
Est. shares
0 shares
NeoGenomics (NEO) Earnings per Share (EPS) History
Signup for full accessBrowse free
NeoGenomics (NEO) Latest Earnings
The value each NEO share was expected to gain vs. the value each share gained.
NeoGenomics (NEO) reported its most recent earnings on Feb 18, 2025 for Q4 2024, posting earnings per share (EPS) of $0.04. This exceeded analysts' expectations of $0.03 by 33.33%, marking a Beat.
For comparison, NeoGenomics reported EPS of $0.03 in the same quarter last year.
The company is expected to announce its next earnings report on 07/28/2025, with analysts projecting an EPS of -$0.08.
NeoGenomics (NEO) Earnings History
NeoGenomics (NEO) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the NeoGenomics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Apr 29, 2025 | — | — | — |
Feb 18, 2025 | — | — | — |
Nov 5, 2024 | — | — | — |
Jul 29, 2024 | — | — | — |
NeoGenomics (NEO) Earnings FAQs
NeoGenomics (NEO) last reported earnings on Feb 18, 2025 for Q4 2024, posting an EPS of $0.04, which Beat the estimate of $0.03 by 33.33%.
For Q4 2024, NeoGenomics (NEO) reported an EPS of $0.04, exceeding analysts' estimate of $0.03 by 33.33%.
For Q4 2024, NeoGenomics (NEO) Beat expectations with an actual EPS of $0.04 vs. an estimated EPS of $0.03.
Following the last earnings report on Feb 18, 2025, NeoGenomics (NEO)'s stock price moved — from — to —.
The next NeoGenomics (NEO) earnings call is scheduled for Jul. 28, 2025, where executives will discuss financial results and outlook.